Total Payments
$1,473
2024 Payments
$307.23
Companies
40
Transactions
89
Medicare Patients
1,113
Medicare Billing
$54,822
Payment Breakdown by Category
Food & Beverage$1,299 (88.2%)
Education$173.58 (11.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,299 | 82 | 88.2% |
| Education | $173.58 | 7 | 11.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $201.49 | 9 | $0 (2024) |
| AbbVie Inc. | $135.84 | 9 | $0 (2023) |
| AMAG Pharmaceuticals, Inc. | $98.59 | 6 | $0 (2018) |
| Coloplast Corp | $71.03 | 2 | $0 (2017) |
| Novo Nordisk Inc | $70.65 | 4 | $0 (2024) |
| Avion Pharmaceuticals | $69.36 | 5 | $0 (2019) |
| Collegium Pharmaceutical, Inc. | $63.07 | 4 | $0 (2022) |
| Sumitomo Pharma America, Inc. | $51.32 | 3 | $0 (2024) |
| Daiichi Sankyo Inc. | $48.01 | 3 | $0 (2022) |
| Exeltis, USA Inc. | $47.48 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $307.23 | 14 | Astellas Pharma US Inc ($159.82) |
| 2023 | $157.56 | 11 | Astellas Pharma US Inc ($41.67) |
| 2022 | $292.15 | 18 | Collegium Pharmaceutical, Inc. ($63.07) |
| 2021 | $160.56 | 12 | AbbVie Inc. ($60.54) |
| 2020 | $39.41 | 3 | Allergan, Inc. ($14.02) |
| 2019 | $170.89 | 11 | Olympus America Inc. ($38.16) |
| 2018 | $148.51 | 10 | Avion Pharmaceuticals ($43.67) |
| 2017 | $196.34 | 10 | AMAG Pharmaceuticals, Inc. ($84.46) |
All Payment Transactions
89 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | MILLICENT US INC | FEMRING (Drug), INTRAROSA | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: TREAT SYMPTOMS OF MENOPAUSE | ||||||
| 11/25/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: Biological | ||||||
| 11/07/2024 | Sage Therapeutics, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $26.50 | General |
| Category: PSYCHIATRY/PSYCHOLOGY | ||||||
| 10/01/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: UROLOGY | ||||||
| 09/19/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: Obesity | ||||||
| 09/05/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: Obesity | ||||||
| 08/15/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 05/16/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 04/22/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $74.99 | General |
| 04/22/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Biological | ||||||
| 03/12/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Biological | ||||||
| 02/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: NEUROSCIENCE | ||||||
| 02/05/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: Biological | ||||||
| 01/03/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Biological | ||||||
| 11/27/2023 | Hologic Sales and Service, LLC | OMNI HYSTEROSCOPE (Device) | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: Surgical | ||||||
| 11/07/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: Diabetes | ||||||
| 09/06/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: Biological | ||||||
| 07/31/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Biological | ||||||
| 05/17/2023 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $11.61 | General |
| 05/02/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Urology | ||||||
| 04/24/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: Urology | ||||||
| 04/17/2023 | AbbVie Inc. | ORILISSA (Drug), LO LOESTRIN FE | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: WOMENS HEALTH | ||||||
| 03/16/2023 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: Oral Contraceptive | ||||||
| 02/21/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Urology | ||||||
| 01/19/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 270 | 282 | $34,940 | $13,047 |
| 2022 | 5 | 255 | 263 | $34,285 | $12,888 |
| 2021 | 5 | 339 | 354 | $42,940 | $16,973 |
| 2020 | 5 | 249 | 261 | $32,715 | $11,915 |
Total Patients
1,113
Total Services
1,160
Medicare Billing
$54,822
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 122 | 122 | $11,590 | $4,624 | 39.9% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 105 | 105 | $11,550 | $4,363 | 37.8% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2023 | 19 | 23 | $6,900 | $1,737 | 25.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 20 | $2,500 | $1,329 | 53.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 12 | 12 | $2,400 | $993.55 | 41.4% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 108 | 108 | $10,260 | $4,180 | 40.7% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 95 | 95 | $10,450 | $4,010 | 38.4% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2022 | 24 | 27 | $8,100 | $2,288 | 28.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 16 | 18 | $3,600 | $1,481 | 41.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 15 | $1,875 | $929.23 | 49.6% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 139 | 139 | $15,290 | $5,927 | 38.8% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 150 | 150 | $14,250 | $5,817 | 40.8% |
| 76830 | Ultrasound pelvis through vagina | Office | 2021 | 22 | 22 | $6,600 | $2,031 | 30.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 14 | 19 | $3,800 | $1,672 | 44.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 14 | 24 | $3,000 | $1,525 | 50.8% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 107 | 107 | $10,165 | $4,258 | 41.9% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2020 | 95 | 95 | $10,450 | $4,021 | 38.5% |
| 76830 | Ultrasound pelvis through vagina | Office | 2020 | 19 | 21 | $6,300 | $1,734 | 27.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 16 | 24 | $3,000 | $1,139 | 38.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 12 | 14 | $2,800 | $762.91 | 27.2% |
About Dr. Andrea Tomassoni, MD
Dr. Andrea Tomassoni, MD is a Obstetrics & Gynecology healthcare provider based in Scranton, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104896042.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andrea Tomassoni, MD has received a total of $1,473 in payments from pharmaceutical and medical device companies, with $307.23 received in 2024. These payments were reported across 89 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($1,299).
As a Medicare-enrolled provider, Tomassoni has provided services to 1,113 Medicare beneficiaries, totaling 1,160 services with total Medicare billing of $54,822. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Obstetrics & Gynecology
- Location Scranton, PA
- Active Since 01/24/2006
- Last Updated 08/03/2021
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1104896042
Products in Payments
- Veozah (Drug) $112.17
- Balcoltra (Drug) $69.36
- XTAMPZA (Drug) $63.07
- LO LOESTRIN FE (Drug) $61.64
- MAKENA (Drug) $54.12
- GEMTESA (Drug) $51.32
- INJECTAFER (Drug) $48.01
- SLYND (Drug) $47.48
- ORILISSA (Drug) $47.46
- INTRAROSA (Drug) $44.47
- XARELTO (Drug) $43.33
- FEMALE INCONTINENCE (Device) $41.44
- NEXPLANON (Drug) $39.59
- Wegovy (Drug) $38.57
- ThunderBeat (Device) $38.16
- Mirena (Drug) $32.60
- ALTIS (Device) $29.59
- XIFAXAN (Drug) $29.18
- ZENPEP (Drug) $28.72
- Orilissa (Drug) $27.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Scranton
Dr. Georges Chamoun, Do, DO
Obstetrics & Gynecology — Payments: $62,651
Obstetrics & Gynecology $62,651
Dr. Raymond Decesare, M.d, M.D
Obstetrics & Gynecology — Payments: $7,841
Obstetrics & Gynecology $7,841
Nicole Mcandrew, Do, DO
Obstetrics & Gynecology — Payments: $4,146
Obstetrics & Gynecology $4,146
Dr. Maria Bigus-Coslett, D.o, D.O
Obstetrics & Gynecology — Payments: $3,188
Obstetrics & Gynecology $3,188
Dr. Antoine Naim, Md, MD
Obstetrics & Gynecology — Payments: $2,281
Obstetrics & Gynecology $2,281
Dr. Marc Rabin, M.d, M.D
Obstetrics & Gynecology — Payments: $1,426
Obstetrics & Gynecology $1,426